Arkolith/Insider Trading/CASI/Form 4

He Wei-Wu

Chairman and CEO, DirectorCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Aug 20, 2021
Net Buying
Open-Market Buys
$614K
Open-Market Sells
$0
Net Open-Market Flow
$614K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2021Buy(P)180K$1.26$227K5.2M
Aug 18, 2021Buy(P)300K$1.29$387K5.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-108182) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML